4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000097
Chief Financial Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Adams Kendra Chief Financial Officer | 2023-09-18 | Grant or award | +25,000 | 46,640 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Adams Kendra Chief Financial Officer | 2023-09-18 | Grant or award · Stock Option (Right to Buy) | +111,000 | 111,000 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1695165671.xml…